Back to School: How biopharma can reboot drug development. Access exclusive analysis here

FDA accepts Macugen NDA

By BC Staff | Aug 17, 2004 | 7:00 AM GMT

Eyetech (EYET) and partner Pfizer (PFE) said the FDA accepted for

Read the full 115 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE